Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage

Author(s):  
Antonio Dopico-López ◽  
María Pérez-Mato ◽  
Andrés da Silva-Candal ◽  
Ramón Iglesias-Rey ◽  
Aharon Rabinkov ◽  
...  
2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
J. Suc ◽  
A. Purbojo ◽  
A. Rüffer ◽  
A. Koch ◽  
K.P. Eberle ◽  
...  
Keyword(s):  

Nutrients ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 181
Author(s):  
Woosuk Kim ◽  
Hyo Young Jung ◽  
Dae Young Yoo ◽  
Hyun Jung Kwon ◽  
Kyu Ri Hahn ◽  
...  

Gynura procumbens has been used in Southeast Asia for the treatment of hypertension, hyperglycemia, and skin problems induced by ultraviolet irradiation. Although considerable studies have reported the biological properties of Gynura procumbens root extract (GPE-R), there are no studies on the effects of GPE-R in brain damages, for example following brain ischemia. In the present study, we screened the neuroprotective effects of GPE-R against ischemic damage and neuroinflammation in the hippocampus based on behavioral, morphological, and biological approaches. Gerbils received oral administration of GPE-R (30 and 300 mg/kg) every day for three weeks and 2 h after the last administration, ischemic surgery was done by occlusion of both common carotid arteries for 5 min. Administration of 300 mg/kg GPE-R significantly reduced ischemia-induced locomotor hyperactivity 1 day after ischemia. Significantly more NeuN-positive neurons were observed in the hippocampal CA1 regions of 300 mg/kg GPE-R-treated animals compared to those in the vehicle-treated group 4 days after ischemia. Administration of GPE-R significantly reduced levels of pro-inflammatory cytokines such as interleukin-1β, -6, and tumor necrosis factor-α 6 h after ischemia/reperfusion. In addition, activated microglia were significantly decreased in the 300 mg/kg GPE-R-treated group four days after ischemia/reperfusion compared to the vehicle-treated group. These results suggest that GPE-R may be one of the possible agents to protect neurons from ischemic damage by reducing inflammatory responses.


1998 ◽  
Vol 782 (1-2) ◽  
pp. 212-218 ◽  
Author(s):  
Magali Reyes ◽  
Ayesha Reyes ◽  
Thoralf Opitz ◽  
Michael A Kapin ◽  
Patric K. Stanton

2008 ◽  
Vol 179 (4S) ◽  
pp. 327-327
Author(s):  
Yasuhito Funahashi ◽  
Ryohei Hattori ◽  
Osamu Kamihira ◽  
Tokunori Yamamoto ◽  
Momokazu Gotoh

2005 ◽  
Vol 47 (1-3) ◽  
pp. 139-144 ◽  
Author(s):  
Masaya Nagao ◽  
Tong-Chun Wen ◽  
Masaya Okamoto ◽  
Kazuhiro Irie ◽  
Takeshi Takaku ◽  
...  

1982 ◽  
Vol 77 (5) ◽  
pp. 465-485 ◽  
Author(s):  
F. Z. Meerson ◽  
V. E. Kagan ◽  
Yu. P. Kozlov ◽  
L. M. Belkina ◽  
Yu. V. Arkhipenko

2009 ◽  
Vol 26 (5) ◽  
pp. E24 ◽  
Author(s):  
Raymond Choi ◽  
Robert H. Andres ◽  
Gary K. Steinberg ◽  
Raphael Guzman

Increasing evidence in animal models and clinical trials for stroke, hypoxic encephalopathy for children, and traumatic brain injury have shown that mild hypothermia may attenuate ischemic damage and improve neurological outcome. However, it is less clear if mild intraoperative hypothermia during vascular neurosurgical procedures results in improved outcomes for patients. This review examines the scientific evidence behind hypothermia as a treatment and discusses factors that may be important for the use of this adjuvant technique, including cooling temperature, duration of hypothermia, and rate of rewarming.


Sign in / Sign up

Export Citation Format

Share Document